1 / 27

Monoclonal Antibodies

Monoclonal Antibodies. In Nuclear Medicine – Understanding The Basics. Information on You Tube. Suggested review prior to this lecture Role of B Lymphocytes http://www.youtube.com/watch?v=Z36dUduOk1Y Production of Monoclonal Antibodies http://www.youtube.com/watch?v=O-SrPqJuEVg.

joyceadam
Download Presentation

Monoclonal Antibodies

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Monoclonal Antibodies In Nuclear Medicine – Understanding The Basics

  2. Information on You Tube Suggested review prior to this lecture • Role of B Lymphocytes • http://www.youtube.com/watch?v=Z36dUduOk1Y • Production of Monoclonal Antibodies • http://www.youtube.com/watch?v=O-SrPqJuEVg

  3. Basic Concepts • Antibodies [Ab] (Immunoglobulins [Ig]) are produced by plasma cells in response to foreign substances (Antigens [Ag]) • Ag are usually 1,000 daltons or more in size • Ig possess specific binding regions on the surface that recognize the shape of particular sites (determinants) on the surface of an Ag • Ab binds to the Ag in an immunological response destroying the Ag • What’s the size of a dalton?

  4. Ab Response • Ag usually have several determinants or epitopes • Each epitope stimulates one or more B lymphocytes • B lymphocytes can differentiate into plasma cells that secrete a specific Ig response to a determinate on the Ag • Hence B lymphocytes create plasma cells and the plasma cells produce a host of different Ab in response to the Ag

  5. How Antibodies are developed • Using a mouse or rabbit it is immunized with Ag agent – ex. Cancerous tissue is placed underneath the skin • This creates an Ab to Ag response within the host • Serum can then be extracted from the host that has the Abs which were created from the different epitopes on the Ag surface • This is known as a polyclonal response because there are many types of Abs that were produced from the inoculation of a specific Ag • Refer to the image on the next side to define the process

  6. Ab To Ag Response • This side shows the • mouse response • to the Ag that creates • polyclonal Ab. Important points: • Ag is injected into host • Lymphocytes respond to Ag and produce Abs • Taking lymphocytes from host you can fuse this with Myeloma Cells resulting in hybrid Ab • These polyclonal Abs can be separated into MoAbs • Refer to the • side next to • note MoAb • Production

  7. Where Do MoAbs Come From? • Lymphocytes or Plasma cells are extracted from the mouse and fused with myeloma cells • This creates a hybrid myeloma cells • They are cloned • Specific MoAbs are then grown in culture

  8. A closer look at the process in which MoAbs are produced. The process is discussed on the following slides

  9. Creating the MoAb For Medical Use • Extract the splenic lymphocytes from an immunized mouse along with the myeloma cell line • Fusing these cells creates a hybridoma cells • Fusing occurs in a polyethylene glycol solution where the cell will multiple • Selected hybridoma cells are then grown in a hypoxanthene-aminopterin-thymidine (HAT) medium (only fused cells survive) • These cells can then be separated for assay and are re-cultured (re-cloned) until the right MoAb is found

  10. The Immunoglobulins (Ig) • There many types of Igs: IgG, IgM, IgE, IgA, and IgD • Usually hybridomas are developed from some form of IgG or its subclass • The next slide demonstrates the structure of an IgG MoAb

  11. IgG Structure • Variable region (light chain) respond to the different to the epitopes on the Ag surface • Constant or heavy region remains the same • These chains are held together by a disulfide bonds • Note that the IgG structure can be fragmented via pepsin or papain

  12. Fragmented: F(ab’)2 ,Fab, and Fc • Removal of most or all of the heavy change causes • Reduce HAMA response • Allows for faster clearance after injection • MoAbs have been created from all of the above mentioned types • Can you identify a whole IgG and fragmented IgG used in nuclear medicine? • Discuss some of its imaging properties • Whole IgG is (~50,000 daltons or greater) that metabolize in the liver, while fragmented are much smaller and quickly excreted by the kidneys

  13. Some other points • Total mol.wt. of an IgG is up to ~150,000 daltons • Affinity refers to the strength of attraction between the Ab-Ag • Avidity refers to the integrity of the Ab-Ag bond • Both affinity and avidity are important in order for specific/strong tag to occur between the Ab-Ag

  14. Comment on HAMA • A mouse contains murine Abs • Human response to this could be a human anti-body (HAMA) reaction • Human-human hybridomas should be considered to reduce the HAMA response • HAMA is an allergic reaction • Anaphylactic is the most server and if left unchecked could cause death • Interferes with imaging can also occur creating a false negative image (the body has prevented Ab-Ag to occur because HAMA interferes)

  15. Finding the Right Radionuclide Tag • Consider • Therapy vs. diagnostic (beta vs. gamma) • Type of radionuclide (Tc99m vs. In111) • Tagging whole vs. fragmented IgG

  16. Therapy vs. Diagnostic • Therapy • If beta radiation is used particle radiation can destroy the disease • Requires a strong/stable Ab-Ag reaction • Diagnostic • Gamma radiation is used • Disease is identified • Requires a strong/stable Ab-Ag reaction

  17. The Real Thing • Is this whole or fragmented? • Identify the parts of the MoAb • What would you tag to it? – Therapy vs. Diagnostic • Where is the tag? • What is this type of tag called?

  18. Type of Radionuclide • If the radio-MoAb is the entire IgG • Takes a long time to clear or get a good target to background (72 or more hours) • Requires a radionuclide such as In111 • Fragmented IgG • Clears quickly and gives a better target to background (usually within 24 hours) • Tc99m can be used

  19. More on the Whole IgG MoAb • When using In111 • DTPA is used so that the In111 tags to the heavy change of the MoAb • In111 – DTPA – MoAb (on the heavy change) • In111 is then introduced and tags to the DTPA • Remember In111 must be used if the MoAb being used requires significant filtering by the body, over time • What other gamma emitters could we use if a whole IgG MoAb is being used?

  20. MoAb – Whole vs. Fragmented Both agents are used to image Colon cancer OncoScint’s MoAb is whole, it’s tracer 111In, injection to scan is 3+ days Arcitumomab’s MoAb is fragmented, Tagged to 99Tc, injection to scan is 24 hours What is your assessment of background activity in both procedures?

  21. Complications of the Radioactive Tag • Radiolabeling may alter the biological activity of the MoAb, rendering it either less infective • Immunoreactive fraction is a concern and results when free MoAb dissociates from the radioactive tag • Immunospecificity is another issue where specificity of the agent can be lost. This can occur by any one of the following • Blood flow • Metabolism • Capillary permeability

  22. Target to Background Ratios • Minimal requirement 2:1, but 5:1 is preferred • Digital subtraction and image contrast can help, however, a higher false-positive may occur • Theoretically 100:1 to 1000:1 ratios should be attained, however, this has never happened • To make an idea MoAb consider the following: MoAb clearance, reducing background, reducing dosimetry, and reducing HAMA favor the fragmented MoAb

  23. Clinical Status • MoAbs have been created to identify • Lung Cancer • Prostate Cancer • Colon Cancer • Infection • Lymphoma • Still lacks sensitivity and specificity • Is it the poor man’s PET? • When you look at the sensitivity and specificity of PET over MoAbs, you might conclude that MoAbs are the inferior scan (see PET lecture)

  24. Review of the Issues • Excessive background (more so with whole IgG) • Ionization of the radioactive tag (losses specificity) • Cross-reactivity with non-specific Ag (goes where you don’t want it to) • Variation of expression Ab-Ag can result in a false –negative study • HAMA response to the IgG reduces image quality • Alternate routes of administration should be considered

  25. ProstaScint and CEA Scan This is an example of Prostate mets

  26. MDP vs MoAb http://www.nature.com/ncpuro/journal/v3/n4/fig_tab/ncpuro0452_F2.html

  27. For more information you can access the following article: “Monoclonal Antibodies in Nuclear Medicine”, by AM. Keenan, Et al. Jour NM, May 1985 10/14 http://www.med.harvard.edu/JPNM/physics/pharms/radpharm/antibod/FDAnov96.html Return to the Table of Content

More Related